First Time Loading...

Vanda Pharmaceuticals Inc
NASDAQ:VNDA

Watchlist Manager
Vanda Pharmaceuticals Inc Logo
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Watchlist
Price: 4.82 USD 4.33% Market Closed
Updated: Apr 30, 2024
Section:
 

Relative Value

The Relative Value of one VNDA stock under the Base Case scenario is 11.94 USD. Compared to the current market price of 4.82 USD, Vanda Pharmaceuticals Inc is Undervalued by 60%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VNDA Relative Value
Base Case
11.94 USD
Undervaluation 60%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.4
P/S
P/S
Price to Sales
1.4
vs History
82
vs Industry
85
Median 3Y
2.2
Median 5Y
2.5
Industry
8.1
Forward
1.4
More Details
110.5
P/E
P/E
Price to Earnings
110.5
vs History
0
vs Industry
1
Median 3Y
31
Median 5Y
28.9
Industry
26.2
Forward
-78.8
More Details
21.7
P/OCF
P/OCF
Price to OCF
21.7
vs History
6
vs Industry
8
Median 3Y
13.2
Median 5Y
14.1
Industry
22.6
More Details
22.3
P/FCFE
P/FCFE
Price to FCFE
22.3
vs History
6
vs Industry
7
Median 3Y
13.4
Median 5Y
14.5
Industry
21.3
More Details
0.5
P/B
P/B
Price to Book Value
0.5
vs History
87
vs Industry
73
Median 3Y
1.1
Median 5Y
1.3
Industry
2.5
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0.5
Median 5Y
1
Industry
7.3
Forward
-0.6
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0.5
Median 5Y
1.1
Industry
9.1
More Details
10.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.1
vs History
47
vs Industry
10
Median 3Y
9.4
Median 5Y
10.9
Industry
4.4
More Details
8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
8
vs History
69
vs Industry
10
Median 3Y
10.8
Median 5Y
12.5
Industry
4.3
Forward
5.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
2.1
Median 5Y
5.9
Industry
5.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
2.2
Median 5Y
6.1
Industry
3.2
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
Median 3Y
0.8
Median 5Y
1.5
Industry
5
More Details

Multiples Across Competitors

VNDA Competitors Multiples
Vanda Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
277.3m USD 1.4 110.5 10.1 8
US
Abbvie Inc
NYSE:ABBV
281.9B USD 5.2 58.5 12.7 19.4
US
Amgen Inc
NASDAQ:AMGN
146.2B USD 5.2 21.8 16.2 24.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102B USD 10.3 28.2 22.5 23.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
97.7B USD 7.4 24.7 16.3 18
AU
CSL Ltd
ASX:CSL
132.9B AUD 6.2 35.3 21.4 26.5
US
Gilead Sciences Inc
NASDAQ:GILD
82.9B USD 3.1 14.6 8 10.3
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
42.4B USD 6.2 -9 -9.5 -8.1
US
Biogen Inc
NASDAQ:BIIB
31.6B USD 3.2 27.2 14.7 18.2
KR
Celltrion Inc
KRX:068270
38.1T KRW 17.5 71.1 43.5 59.9

See Also

Summary
VNDA intrinsic value, competitors valuation, and company profile.
DCF Valuation
VNDA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VNDA stock valuation using valuation multiples.
Wall Street Estimates
VNDA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VNDA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.